Articles from Phreesia, Inc.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024.

Phreesia, a leader in patient intake, outreach and activation, has been selected by The Software Report as one of the “Top 100 Software Companies of 2024.” The annual program evaluates companies based on a range of criteria, including product functionality, customer satisfaction, corporate reputation, innovative capabilities, organizational depth, ESG involvement and long-term viability. This is the third consecutive year Phreesia has been named to the list.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day.

Phreesia, a leader in patient intake, outreach and activation, and a member of Oracle PartnerNetwork (OPN), today announced that it has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its integration of the Phreesia platform. Phreesia gives clients a suite of tools to manage patient intake across care settings and service lines. Its logic-driven tools enable healthcare organizations to operate more efficiently and provide a high-quality patient experience at scale.

As part of the company’s ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy.

Phreesia, a leader in patient intake, outreach and activation, has collaborated with the Ad Council, a nonprofit organization at the forefront of driving change through social impact marketing, to bring three public health campaigns about mental health directly to patients and caregivers. Collectively across the campaigns, Phreesia has already delivered more than 430,000 messages, helping to spread awareness about the importance of youth and adult mental wellbeing and encouraging more open conversations about mental health.

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that its contract with the CMS Innovation Center (CMMI) for use of the Patient Activation Measure® (PAM) has been renewed through 2029. The PAM performance measure, which assesses gains in patients’ knowledge, skills and confidence in managing their own healthcare, is one of the first patient-reported outcome performance measures (PRO-PMs) used in a CMS alternative payment model. Under the new contract, Phreesia will provide access to PAM, training, analysis and other support to the Kidney Care Choices Model (KCC). CMMI also has the option to expand the PAM into additional models, including those focused on other disease states, care settings or episodes of care.

New Phreesia research examining more than 20.2 million digital vaccine messages indicates that providing adults and caregivers with vaccine information just before their appointments, or at the point of care, is an effective strategy for supporting vaccine confidence and adoption, including among historically marginalized populations.

Phreesia, a leader in patient intake, outreach and activation, together with the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence (UI) in women.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2025 financial results after the close of market trading on Wednesday, Sept. 4, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2025 financial results after the close of market trading on Thursday, May 30, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal fourth quarter results starting at 5PM Eastern Time on the same day.

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023.

Phreesia today announced its patient intake platform and data centers have earned certified status by HITRUST for information security.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tuesday, December 5, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2023.

On July 13, 2023, Phreesia, Inc.’s (“Phreesia”) Board of Directors approved the grant of restricted stock unit awards pursuant to Phreesia’s 2023 Inducement Award Plan (the “Plan”). On August 15, 2023, Phreesia made grants pursuant to the Plan in an aggregate amount of 12,285 shares of its common stock to 24 new non-executive employees to induce them to join Phreesia. The awards vest annually in equal installments over a four-year period following their grant, subject to continued employment. Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2024 financial results after the close of market trading on Wednesday, September 6, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5 PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2023 financial results after the close of market trading on Wednesday, March 22, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal fourth quarter results starting at 5 PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the third quarter ended October 31, 2022.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2023 financial results after the close of market trading on Thursday, December 8, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5:00 PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wednesday, September 7, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5:00 PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2022.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2023 financial results after the close of market trading on Thursday, June 2, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5:00 PM Eastern Time on the same day.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2022.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) announced financial results today for the fiscal third quarter ended October 31, 2021.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) will hold a conference call on Thursday, December 9, 2021, at 8:45 a.m. Eastern Time to discuss the Company's fiscal third quarter 2022 financial results. A press release announcing the fiscal third quarter financial results will be issued after the close of market trading on Wednesday, December 8, 2021.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) announced financial results today for the fiscal second quarter ended July 31, 2021.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) will hold a conference call on Thursday, September 2, 2021, at 8:30 a.m. Eastern Time to discuss the Company's fiscal second quarter 2022 financial results. A press release announcing the fiscal second quarter financial results will be issued after the close of market trading on Wednesday, September 1, 2021.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) announced financial results today for the fiscal first quarter ended April 30, 2021.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) will hold a conference call on Friday, June 4, 2021, at 8:30 a.m. Eastern Time to discuss the Company's fiscal first quarter 2022 financial results. A press release announcing the fiscal first quarter financial results will be issued after the close of market trading on Thursday, June 3, 2021.

Phreesia, Inc. (the “Company”) (NYSEPHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,175,000 shares of its common stock (the “Offering”) all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of $50.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.

Phreesia, Inc. (“Phreesia”) (NYSEPHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the “Offering”) at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts.

Phreesia, Inc. (“Phreesia”) (NYSEPHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the actual size and terms of the offering.